President & COO of United Therapeutics Corp. (UTHR) Roger Jeffs sells 5,000 shares of UTHR on 08/03/2012 at an average price of $54.02 a share.

United Therapeutics Corporation has a market cap of $2.93 billion; its shares were traded at around $53.89 with a P/E ratio of 11.7 and P/S ratio of 3.9.

This is the annual revenues and earnings per share of UTHR over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of UTHR.

CEO Recent Trades:

• CEO Martine A Rothblatt bought 3,960 shares of UTHR stock on 06/20/2012 at the average price of 47.95. Martine A Rothblatt owns at least 690,602 shares after this. The price of the stock has increased by 12.39% since.
• CEO Martine A Rothblatt bought 4,138 shares of UTHR stock on 06/19/2012 at the average price of 47.94. Martine A Rothblatt owns at least 686,642 shares after this. The price of the stock has increased by 12.41% since.
• CEO Martine A Rothblatt bought 4,130 shares of UTHR stock on 06/18/2012 at the average price of 48. Martine A Rothblatt owns at least 682,504 shares after this. The price of the stock has increased by 12.27% since.
• CEO Martine A Rothblatt bought 4,230 shares of UTHR stock on 06/15/2012 at the average price of 46.97. Martine A Rothblatt owns at least 678,374 shares after this. The price of the stock has increased by 14.73% since.
• CEO Martine A Rothblatt bought 4,400 shares of UTHR stock on 06/14/2012 at the average price of 45.23. Martine A Rothblatt owns at least 674,144 shares after this. The price of the stock has increased by 19.15% since.

CFO Recent Trades:

• CFO John Maxim Ferrari sold 5,500 shares of UTHR stock on 07/19/2012 at the average price of 53.32. The price of the stock has increased by 1.07% since.
• CFO John Maxim Ferrari sold 121,000 shares of UTHR stock on 07/05/2012 at the average price of 52.3. The price of the stock has increased by 3.04% since.

This is the insider trade history vs. stock price of UTHR. For the complete insider trading history of UTHR, click here.

Directors and Officers Recent Trades:

• Director Christopher Causey sold 1,500 shares of UTHR stock on 08/02/2012 at the average price of 53.49. Christopher Causey owns at least 1,183 shares after this. The price of the stock has increased by 0.75% since.
• Director Christopher Patusky sold 2,000 shares of UTHR stock on 08/01/2012 at the average price of 54.69. Christopher Patusky owns at least 1,300 shares after this. The price of the stock has decreased by 1.46% since.
• Director Ray Kurzweil sold 5,766 shares of UTHR stock on 07/31/2012 at the average price of 54.78. The price of the stock has decreased by 1.62% since.
• President & COO Roger Jeffs sold 5,000 shares of UTHR stock on 07/20/2012 at the average price of 52.46. Roger Jeffs owns at least 25,636 shares after this. The price of the stock has increased by 2.73% since.
• EVP & General Counsel Paul A Mahon sold 6,000 shares of UTHR stock on 07/19/2012 at the average price of 53.32. Paul A Mahon owns at least 33,600 shares after this. The price of the stock has increased by 1.07% since.

For the complete insider trading history of UTHR, click here.

Why CEOs Are Buying Stocks Of Their Own Companies?

1. As legendary investor Peter Lynch said: "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise."
2. TOP EXECUTIVES like CEOs and CFOs are savvy buyers of their companies' shares. One long-term study showed that they beat the market on average by six percentage points a year.
3. Another study found that the aggregated activities of insiders can serve as a good indicator to locate market bottoms. Insiders as a whole are smart investors of their own companies.

Click it to Check Out What the CEO Are Trading

More Gurufocus Links

Latest Guru Picks	Value Strategies
Warren Buffett Portfolio	Ben Graham Net-Net
Real Time Picks	Buffett-Munger Screener
Aggregated Portfolio	Undervalued Predictable
ETFs, Options	Low P/S Companies
Insider Trends	10-Year Financials
52-Week Lows	Interactive Charts
Model Portfolios	DCF Calculator
RSS Feed	Monthly Newsletters
The All-In-One Screener	Portfolio Tracking Tool